Exxon Mobil leads fresh analyst reports as Permian and Guyana output power growth, while Palantir's AI platforms and ...

Broker upgrades odds on AVANZAR lung cancer trial after arguing repeated delays signal strong results in treatment arm Jefferies has lifted its price target on AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), ...

AstraZeneca's shares jumped after Pfizer's announcement of a major deal with the Trump administration. Pfizer's good news could benefit AstraZeneca, too. 10 stocks we like better than AstraZeneca Plc ...

The latest announcement is out from AstraZeneca ( (GB:AZN) ).

The pharmaceutical sector veteran reported a prosperous quarter on Tuesday. It posted double-digit increases in key fundamentals. 10 stocks we like better than AstraZeneca Plc › AstraZeneca (NASDAQ: ...

On Wednesday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Koselugo (selumetinib) granules and capsules for pediatric patients 1 year of age and older with ...

AstraZeneca PLC and Daiichi Sanyko Co Ltd on Monday reported that their co-developed breast cancer treatment Enhertu had secure priority review status in the US. Enhertu, or famtrastuzumab ...

The pharmaceutical sector mainstay reported good news about its developmental hypertension drug. It purchased the medicine's maker, CinCor Pharma, in early 2023. Early this morning, AstraZeneca shared ...

February 2026 AstraZeneca prices a $2bn bond offering AstraZeneca PLC ("AstraZeneca") announces that its wholly owned subsidiary AstraZeneca Finance LLC, priced a three tranche global bond offering ...

AstraZeneca PLC closed 0.08% below its 52-week high of £155.54, which the company achieved on February 24th.

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best healthcare stocks to buy for 2026. On January 29, AstraZeneca announced a $15 billion investment in China through 2030 to expand manufacturing and R&D, ...